Affiliation:
1. Postgraduate Program in Natural and Bioactive Synthetic Products, Department of Pharmaceutical Sciences Federal University of Paraiba João Pessoa Paraíba Brazil
2. Biochemistry Laboratory, Academic Unit of Health, Education and Health Center Federal University of Campina Grande Cuité Paraíba Brazil
3. Bioenergy and Organic Synthesis Research Laboratory, Department of Chemistry University of Paraiba João Pessoa Paraíba Brazil
Abstract
Abstract
Aims
This study evaluated the antifungal, antibiofilm and molecular docking of 2-chloro-N-phenylacetamide against clinical isolates of Candida tropicalis and Candida parapsilosis.
Methods and results
Minimum inhibitory concentration (MIC) of the test drugs was determined by microdilution. A1Cl obtained MIC values ranging from 16 and 256 μg/ml. Fluconazole MIC ranging from 16 and 512 μg/ml. MIC of A1Cl showed fungicide activity, emphasizing the solid antifungal potential of this drug. An association study was performed with A1Cl and fluconazole (checkerboard), revealing indifference by decreasing. Thus, we conducted this study using A1Cl isolated. In the micromorphological assay, the test drugs reduced the production of virulence structures compared to the control (concentration-dependent effect). A1Cl inhibited in vitro biofilm formation at all concentrations tested (1/4MIC to 8 × MIC) (p < 0.05) and reduced mature biofilm biomass (p < 0.05) against C. tropicalis and C. parapsilosis. In the ex vivo biofilm susceptibility testing (human nails fragments), A1Cl inhibited biofilm formation and reduced mature biofilm biomass (p < 0.05) more than 50% at MIC. Fluconazole had a similar effect at 4 × MIC. In silico studies suggest that the mechanism of antifungal activity of A1Cl involves the inhibition of the enzyme dihydrofolate reductase (DHFR) rather than geranylgeranyltransferase-I.
Conclusions
The results suggest that A1Cl is a promising antifungal agent. Furthermore, this activity is related to attenuation of expression of virulence factors and antibiofilm effects against C. tropicalis and C. parapsilosis.
Significance and impact of the study
Our study provides the first evidence that A1Cl, a novel synthetic drug, has fungicidal effects against C. tropicalis and C. parapsilosis. Furthermore, in vitro and ex vivo biofilms assays have demonstrated the potential antibiofilm of A1Cl. The mechanism of action involves inhibiting the enzyme DHFR, which was supported by in silico analyses. Therefore, this potential can be explored as a therapeutic alternative for onychomycosis and, at the same time, contribute to decreasing the resistance of clinical isolates of C. tropicalis and C. parapsilosis.
Funder
CNPq
CAPES
Federal University of Paraíba
Publisher
Oxford University Press (OUP)
Subject
Applied Microbiology and Biotechnology,General Medicine,Biotechnology
Reference50 articles.
1. Docking prediction, antifungal activity, anti-biofilm effects on Candida spp., and toxicity against human cells of cinnamaldehyde;Alves;Molecules,2020
2. Effect of Schinus terebinthifolius on Candida albicans growth kinetics, cell wall formation and micromorphology;Alves;Acta Odontologica Scandinavica,2013
3. Candida onychomycosis: an old problem in modern times;Andrés;Current Fungal Infection Reports,2020
4. Prevalence of Candida tropicalis and Candida krusei in onychomycosis in João Pessoa, Paraiba, Brazil from 1999 to 2010;Arrua;Proceedings of the Brazilian Academy of Sciences,2015
5. The regulatory repert oire of Pseudomonas aeruginosa AmpC ß-lactamase regulator AmpR includes virulence genes;Balasubramanian;PLoS ONE,2012
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献